For: | Fernández-Rodríguez CM, Gutiérrez-García ML. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B. World J Gastrointest Pharmacol Ther 2014; 5(3): 175-182 [PMID: 25133046 DOI: 10.4292/wjgpt.v5.i3.175] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v5/i3/175.htm |
Number | Citing Articles |
1 |
Mei Wang, Congxin Wei, Zhaojuan Shi, Jianzhong Zhu. Study on the diagnosis of small hepatocellular carcinoma caused by hepatitis B cirrhosis via multi‑slice spiral CT and MRI. Oncology Letters 2017; doi: 10.3892/ol.2017.7313
|
2 |
Anastasiya Kostyusheva, Dmitry Kostyushev, Sergey Brezgin, Elena Volchkova, Vladimir Chulanov. Clinical Implications of Hepatitis B Virus RNA and Covalently Closed Circular DNA in Monitoring Patients with Chronic Hepatitis B Today with a Gaze into the Future: The Field Is Unprepared for a Sterilizing Cure. Genes 2018; 9(10): 483 doi: 10.3390/genes9100483
|
3 |
Yoonjung Jang, Won Lee, Sei Sai, Jeong Kim, Jong-Ki Kim, Eun Kim. Tumor‑treating fields in combination with sorafenib restrain the proliferation of liver cancer in vitro. Oncology Letters 2022; 24(4) doi: 10.3892/ol.2022.13458
|
4 |
Lianzhu Wang, Anjun Zhang, Wei Liu, Hui Liu, Fan Su, Ling Qi. Effects of dexmedetomidine on perioperative stress response, inflammation and immune function in patients with different degrees of liver cirrhosis. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6665
|
5 |
Alvaro Lucci, Marina C. Vera, Carla G. Comanzo, Florencia Lorenzetti, Anabela C. Ferretti, María Paula Ceballos, Ariel D. Quiroga, María de Luján Alvarez, María Cristina Carrillo. Delta-tocotrienol enhances the anti-tumor effects of interferon alpha through reactive oxygen species and Erk/MAPK signaling pathways in hepatocellular carcinoma cells. Canadian Journal of Physiology and Pharmacology 2022; 100(5): 453 doi: 10.1139/cjpp-2021-0606
|
6 |
Shanshan Chen, Hao Chen, Shanshan Gao, Shili Qiu, Hu Zhou, Mingxia Yu, Jiancheng Tu. Differential expression of plasma microRNA‐125b in hepatitis B virus‐related liver diseases and diagnostic potential for hepatitis B virus‐induced hepatocellular carcinoma. Hepatology Research 2017; 47(4): 312 doi: 10.1111/hepr.12739
|
7 |
Marina C. Vera, Florencia Lorenzetti, Alvaro Lucci, Carla G. Comanzo, María P. Ceballos, Gerardo B. Pisani, María de L. Alvarez, Ariel D. Quiroga, María C. Carrillo. Vitamin K2 supplementation blocks the beneficial effects of IFN-α-2b administered on the early stages of liver cancer development in rats. Nutrition 2019; 59: 170 doi: 10.1016/j.nut.2018.08.016
|
8 |
Tina Boortalary, Brianna Shinn, Dina Halegoua-DeMarzio, Hie-Won Hann. Liver Cancer. 2021; : 109 doi: 10.36255/exonpublications.livercancer.2021.ch6
|
9 |
Darmadi Darmadi, Dharma Lindarto, Jelita Siregar, Tri Widyawati, Muhammad Rusda, Mustafa Mahmud Amin, Fauzi Yusuf, Putri Chairani Eyanoer, Masrul Lubis, Imelda Rey. Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate. F1000Research 2023; 11: 1521 doi: 10.12688/f1000research.128116.2
|
10 |
Marina C. Vera, Alvaro Lucci, Anabela C. Ferretti, Adriano A. Abbondanzieri, Carla G. Comanzo, Florencia Lorenzetti, Gerardo B. Pisani, María P. Ceballos, Maria de L. Alvarez, María C. Carrillo, Ariel D. Quiroga. The chemoprotective effects of IFN-α-2b on rat hepatocarcinogenesis are blocked by vitamin E supplementation. The Journal of Nutritional Biochemistry 2021; 96: 108806 doi: 10.1016/j.jnutbio.2021.108806
|
11 |
Parham Safaie, Mugilan Poongkunran, Ping-Ping Kuang, Asad Javaid, Carl Jacobs, Rebecca Pohlmann, Imad Nasser, Daryl TY Lau. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(12): 3404-3411 doi: 10.3748/wjg.v22.i12.3404
|
12 |
Yu Zhang, Hongli Liu, Ruitian Yi, Taotao Yan, Yingli He, Yingren Zhao, Jinfeng Liu. Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progression. Journal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0366-3
|
13 |
Negar Rezaei, Farshad Farzad Far, Sara Khademiureh, Ali Sheidaei, Kimiya Gohari, Farnaz Delavari, Mahboubeh Parsaeian, Alireza Delavari, Mahtab Maghsoudlu, Hamid Mohaghegh Shalmani, Zahra Madadi, Anita Mansouri, Moein Yoosefi, Mohsen Asadi-Lari. Liver Cancer Mortality at National and Provincial Levels in Iran Between 1990 and 2015: A Meta Regression Analysis. Hepatitis Monthly 2018; 18(1) doi: 10.5812/hepatmon.62009
|
14 |
Qiushi Tang, Ying Zhao, Yulin Wang, Minjie Wei. A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy. Medical Oncology 2014; 31(11) doi: 10.1007/s12032-014-0267-2
|
15 |
Chunhui Sun, Xun Yao, Qingyu Jiang, Xiuyong Sun. miR-106b targets DAB2 to promote hepatocellular carcinoma cell proliferation and metastasis . Oncology Letters 2018; doi: 10.3892/ol.2018.8970
|
16 |
Qiang Yu, Xia Yang, Weidong Duan, Chonghui Li, Ying Luo, Shichun Lu. miRNA-346 promotes proliferation, migration and invasion in liver cancer. Oncology Letters 2017; 14(3): 3255 doi: 10.3892/ol.2017.6561
|
17 |
|
18 |
Darmadi Darmadi, Dharma Lindarto, Jelita Siregar, Tri Widyawati, Muhammad Rusda, Mustafa Mahmud Amin, Fauzi Yusuf, Putri Chairani Eyanoer, Masrul Lubis, Imelda Rey. Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate. F1000Research 2022; 11: 1521 doi: 10.12688/f1000research.128116.1
|
19 |
Hyo Jung Cho, Bohyun Kim, Jung-Dong Lee, Dae Ryong Kang, Jai Keun Kim, Jei Hee Lee, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Kwang Jae Lee, Soon Sun Kim, Jae Youn Cheong, Sung Won Cho. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver. American Journal of Gastroenterology 2017; 112(3): 460 doi: 10.1038/ajg.2016.480
|
20 |
Patricia Villain, Paula Gonzalez, Maribel Almonte, Silvia Franceschi, Joakim Dillner, Ahti Anttila, Jin Young Park, Hugo De Vuyst, Rolando Herrero. European Code against Cancer 4th Edition: Infections and Cancer. Cancer Epidemiology 2015; 39: S120 doi: 10.1016/j.canep.2015.10.006
|